Rchr

J-GLOBAL ID：200901026785995624 Update date: Aug. 27, 2020

Akiyama Minoru

アキヤマミノル | Akiyama Minoru

Affiliation and department：
Job title：助手
Homepage URL (1)： http://www.shiga-med.ac.jp/~hqgyne/

Research field (2)： Obstetrics and gynecology , Human pathology

Research keywords (4)：臨床病理学 , 婦人科腫瘍学 , Clinical Pathology , Gynecologic oncology

Research theme for competitive and other funds (4)：

子宮頚癌の動注化学療法について
卵巣腫瘍細胞の分化・形質の特性について
Trans-arterial anti-cancer drugs infusion therapy to uterine cervical cancer
Differentiation and phenotype of ovarian neoplasma

MISC (12)：

H Sasaki, S Niimi, M Akiyama, T Tanaka, A Hazato, S Kurozumi, S Fnkushima, M Fukushima. Antitumor activity of 13,14-dihydro-15-deoxy-Delta(7)-prostaglandin-A(1)-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo. CANCER RESEARCH. 1999. 59. 16. 3919-3922
M Akiyama, H Okabe, K Takakura, Y Fujiyama, Y Noda. Expression of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in human endometrium throughout the menstrual cycle. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 1999. 106. 7. 725-730
Follow up of women with simple ovarian cysts detected by transuaginal sonography in the Tokyo metropolitan area. (共著). British Journal of Obstetrics and Gynaecology. 1999. 106. 5. 415-420
当科における16年間のIIb期以上の進行子宮頸癌の治療成績. 産婦人科の進歩. 1997. 49. 4. 429-432
The therapeutic results in aduanced uterine cervical cancer for 16 years. Atuanes in obstetrics and gynecology. 1997. 49. 4. 429-432

ｍore...

Education (2)：

- 1989 Shiga University of Medical Science Undergraduate School of Medicine
- 1989 Shiga University of Medical Science Faculty of Medicine

Professional career (1)：

Doctor of Medical Science (Shiga University of Medical Science)

Association Membership(s) (5)：

米国臨床腫瘍学会(American Society of Clinical Oncology) , 米国癌学会(American Association for Cancer Research) , 日本臨床細胞学会 , 日本癌治療学会 , 日本産科婦人科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM